Elotuzumab: no benefit for older patients with newly diagnosed multiple myeloma Comment

被引：0
|
作者：
Touzeau, Cyrille [1 ,2 ]
机构：
[1] Univ Hosp Hotel Dieu, Dept Hematol, F-44093 Nantes, France
[2] CNRS, Ctr Rech Cancerol & Immunol Integree Nantes Anger, INSERM, UMR 6075,UMR 1307, Nantes, France
来源：
LANCET HAEMATOLOGY | 2022年 / 9卷 / 06期
关键词：
TRANSPLANT-INELIGIBLE PATIENTS; OPEN-LABEL; DEXAMETHASONE; LENALIDOMIDE; BORTEZOMIB; PHASE-3;
D O I：
10.1016/S2352-3026(22)00132-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E386 / E387
页数：2
相关论文
共 50 条
  • [21] Protein Z in patients with newly diagnosed multiple myeloma
    Oleksiuk, J.
    Luksza, E.
    Kloczko, J.
    Galar, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 793 - 793
  • [22] Burden of Treatment Among Older Adults With Newly Diagnosed Multiple Myeloma
    Mian, Hira S.
    Fiala, Mark A.
    Wildes, Tanya M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (02): : E152 - E159
  • [23] Exploring Indicators of Vulnerability in Older Adults With Newly Diagnosed Multiple Myeloma
    Wildes, Tanya M.
    JCO CLINICAL CANCER INFORMATICS, 2024, 8
  • [24] Elotuzumab in multiple myeloma
    Burki, Talha Khan
    LANCET ONCOLOGY, 2018, 19 (12): : E675 - E675
  • [25] Presenting Characteristics and Symptom Burden of Newly Diagnosed Older Multiple Myeloma Patients in the Commpass Study
    Keller, Jesse
    Fiala, Mark A.
    Slade, Michael
    Stockerl-Goldstein, Keith
    Tomasson, Michael
    Wildes, Tanya M.
    Vij, Ravi
    BLOOD, 2015, 126 (23)
  • [26] Thrombotic complications in patients with newly diagnosed multiple myeloma treated with lenalidomide and dexamethasone: benefit of aspirin prophylaxis
    Zonder, JA
    Barlogie, B
    Durie, BGM
    McCoy, J
    Crowley, J
    Hussein, MA
    BLOOD, 2006, 108 (01) : 403 - 403
  • [27] Elotuzumab in multiple myeloma
    Bruzzese, Antonella
    Martino, Enrica Antonia
    Vigna, Ernesto
    Iaccino, Enrico
    Mendicino, Francesco
    Lucia, Eugenio
    Olivito, Virginia
    Filippelli, Gianfranco
    Neri, Antonino
    Morabito, Fortunato
    Gentile, Massimo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (01) : 7 - 10
  • [28] Newly diagnosed multiple myeloma.
    Weber D.M.
    Current Treatment Options in Oncology, 2002, 3 (3) : 235 - 245
  • [29] Bortezomib in newly diagnosed multiple myeloma
    James R. Berenson
    Nature Reviews Clinical Oncology, 2009, 6 : 255 - 256
  • [30] Treatment of newly diagnosed multiple myeloma
    Palumbo A.
    Magarotto V.
    Larocca A.
    Bringhen S.
    Falco P.
    Di Raimondo F.
    Baldini L.
    Boccadoro M.
    Current Hematologic Malignancy Reports, 2008, 3 (2) : 107 - 114
12345